Pathways to the elimination of hepatitis C: prioritising access for all

Alisa E. Pedrana, Rachel Sacks-Davis, Joseph S. Doyle, Margaret E. Hellard

Research output: Contribution to journalEditorialOtherpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)1023-1026
Number of pages4
JournalExpert Review of Clinical Pharmacology
Issue number10
Publication statusPublished - 3 Oct 2017


  • Cost-effectiveness
  • disease elimination
  • hepatitis C virus
  • IDU
  • implementation science
  • models of care
  • testing

Cite this